GlassScriptPhysician profile
Kin Ching Kong
NPI 1376538025
$3,641.25
in general payments reported to CMS, 2019-2025
17 companies · $685 in 2025
The $685 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $185 · 2021: $194 · 2022: $208 · 2023: $698 · 2024: $940 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $838.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $764.29 | 2020-2024 | Arexvy, Shingrix |
| Astellas Pharma US INC | $418.15 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $255.62 | 2023-2025 | Slynd, Twirla |
| Avion Pharmaceuticals | $254.08 | 2019-2022 | |
| Gilead Sciences, INC. | $249.73 | 2019-2024 | Epclusa |
| Organon LLC | $160.28 | 2023-2025 | Jada System, Nexplanon |
| Baxter Healthcare | $143.72 | 2024 | Starling System |
| Hologic Sales and Service, LLC | $141.33 | 2024 | Acessa Provu System, Omni Hysteroscope, Novasure |
| Tandem Diabetes Care, INC. | $138.18 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Axsome Therapeutics, INC. | $125.00 | 2025 | Auvelity |
| Channel Medsystems, INC. | $76.38 | 2023 | |
| Myovant Sciences INC. | $16.35 | 2022 | |
| Mission Pharmacal Company | $15.91 | 2019 | |
| Coopersurgical, INC. | $14.86 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.81 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kin Ching Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.